Clinical Trials Directory

Trials / Unknown

UnknownNCT05083650

Large Macular Hole Closure Rate With Amniotic Membrane Graft With and Without Limitorrhexis

Comparison of Macular Hole Closure Rate in Patients With Poor Prognosis Clinical Features Treated With Amniotic Membrane Graft With and Without Limitorrhexis

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
16 (estimated)
Sponsor
Instituto de Oftalmología Fundación Conde de Valenciana · Academic / Other
Sex
All
Age
40 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Patients with idiopathic macular holes (MHs) postoperative closure rates for large MHs (diameter \> 550 μm) are disappointing and often require a second intervention, different techniques have been described with very variable success rates in different published studies, an efficient technique with good functional outcome has not been found.

Detailed description

Interventional study in large macular holes (diameter \> 550 μm) using an amniotic membrane with and without internal limiting membrane peeling.

Conditions

Interventions

TypeNameDescription
PROCEDUREMacular hole closure with amniotic membrane with/without internal limiting membrane peelingPars plana vitrectomy with/without internal limiting membrane peeling, amniotic membrane, and air tamponade

Timeline

Start date
2021-03-10
Primary completion
2022-12-10
Completion
2023-03-10
First posted
2021-10-19
Last updated
2021-10-19

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT05083650. Inclusion in this directory is not an endorsement.